Found: 36
Select item for more details and to access through your institution.
Multiple myeloma: A prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironment.
- Published in:
- Journal of Cellular Biochemistry, 2007, v. 101, n. 4, p. 950, doi. 10.1002/jcb.21213
- By:
- Publication type:
- Article
Activation of NF-KB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications.
- Published in:
- Oncogene, 2002, v. 21, n. 37, p. 5673, doi. 10.1038/sj.onc.1205664
- By:
- Publication type:
- Article
Signaling Pathways in Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, p. S12
- By:
- Publication type:
- Article
Continued Progress in Treatment Options for Multiple Myeloma: From Past to Present and Future.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 12, p. 1511
- By:
- Publication type:
- Article
Skin Manifestations of Cushing Disease in Children and Adolescents Before and After the Resolution of Hypercortisolemia.
- Published in:
- Pediatric Dermatology, 1998, v. 15, n. 4, p. 253, doi. 10.1046/j.1525-1470.1998.1998015253.x
- By:
- Publication type:
- Article
FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignancies.
- Published in:
- Oncogene, 2005, v. 24, n. 56, p. 8259, doi. 10.1038/sj.onc.1208989
- By:
- Publication type:
- Article
Methyljasmonate displays in vitro and in vivo activity against multiple myeloma cells.
- Published in:
- British Journal of Haematology, 2012, v. 159, n. 3, p. 340, doi. 10.1111/j.1365-2141.2012.09253.x
- By:
- Publication type:
- Article
Halofuginone inhibits multiple myeloma growth in vitro and in vivo and enhances cytotoxicity of conventional and novel agents.
- Published in:
- British Journal of Haematology, 2012, v. 157, n. 6, p. 718, doi. 10.1111/j.1365-2141.2012.09120.x
- By:
- Publication type:
- Article
Managing multiple myeloma: the emerging role of novel therapies and adapting combination treatment for higher risk settings.
- Published in:
- British Journal of Haematology, 2011, v. 154, n. 6, p. 755, doi. 10.1111/j.1365-2141.2011.08791.x
- By:
- Publication type:
- Article
Inhibition of heat shock protein 90 (HSP90) as a therapeutic strategy for the treatment of myeloma and other cancers.
- Published in:
- British Journal of Haematology, 2011, v. 152, n. 4, p. 367, doi. 10.1111/j.1365-2141.2010.08360.x
- By:
- Publication type:
- Article
Molecular and cellular effects of multi-targeted cyclin-dependent kinase inhibition in myeloma: biological and clinical implications.
- Published in:
- British Journal of Haematology, 2011, v. 152, n. 4, p. 420, doi. 10.1111/j.1365-2141.2010.08427.x
- By:
- Publication type:
- Article
Tanespimycin monotherapy in relapsed multiple myeloma: results of a phase 1 dose-escalation study.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 4, p. 438, doi. 10.1111/j.1365-2141.2010.08265.x
- By:
- Publication type:
- Article
In vitro anti-myeloma activity of the Aurora kinase inhibitor VE-465.
- Published in:
- British Journal of Haematology, 2009, v. 147, n. 5, p. 672, doi. 10.1111/j.1365-2141.2009.07891.x
- By:
- Publication type:
- Article
The Medical Research Council Myeloma IX trial: the impact on treatment paradigms.
- Published in:
- European Journal of Haematology, 2012, v. 88, n. 1, p. 1, doi. 10.1111/j.1600-0609.2011.01721.x
- By:
- Publication type:
- Article
Microenvironmental Influence on Pre-Clinical Activity of Polo-Like Kinase Inhibition in Multiple Myeloma: Implications for Clinical Translation.
- Published in:
- PLoS ONE, 2011, v. 6, n. 7, p. 1, doi. 10.1371/journal.pone.0020226
- By:
- Publication type:
- Article
Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 5, p. 756, doi. 10.1111/bjh.14974
- By:
- Publication type:
- Article
Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 6, p. 843, doi. 10.1111/bjh.13382
- By:
- Publication type:
- Article
Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 6, p. 851, doi. 10.1111/bjh.13383
- By:
- Publication type:
- Article
Antitumor Effects of the Proteasome Inhibitor Bortezomib in Medullary and Anaplastic Thyroid Carcinoma Cells in Vitro.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2006, v. 91, n. 10, p. 4013, doi. 10.1210/jc.2005-2472
- By:
- Publication type:
- Article
Epidermal Growth Factor Receptor as a Therapeutic Target in Human Thyroid Carcinoma: Mutational and Functional Analysis.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2006, v. 91, n. 5, p. 3662, doi. 10.1210/jc.2006-0055
- By:
- Publication type:
- Article
Regulation of Vascular Endothelial Growth Factor Expression by Insulin-Like Growth Factor I in Thyroid Carcinomas.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 11, p. 5392, doi. 10.1210/jc.2003-030389
- By:
- Publication type:
- Article
Effect of Imatinib Mesylate (Gleevec) on Anaplastic Thyroid Carcinoma Cell Lines.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 10, p. 5043, doi. 10.1210/jc.2003-030968
- By:
- Publication type:
- Article
The Aromatase Excess Syndrome Is Associated with Feminization of Both Sexes and Autosomal Dominant Transmission of Aberrant P450 Aromatase Gene Transcription.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1998, v. 83, n. 4, p. 1348, doi. 10.1210/jcem.83.4.4697
- By:
- Publication type:
- Article
A genome-wide Drosophila epithelial tumorigenesis screen identifies Tetraspanin 29Fb as an evolutionarily conserved suppressor of Ras-driven cancer.
- Published in:
- PLoS Genetics, 2018, v. 14, n. 10, p. 1, doi. 10.1371/journal.pgen.1007688
- By:
- Publication type:
- Article
Targeting transcription regulation in cancer with a covalent CDK7 inhibitor.
- Published in:
- Nature, 2014, v. 511, n. 7511, p. 616, doi. 10.1038/nature13393
- By:
- Publication type:
- Article
Tanespimycin as antitumor therapy.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Tanespimycin as Antitumor Therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 17, doi. 10.3816/CLML.2011.n.002
- By:
- Publication type:
- Article
Daratumumab augments alloreactive natural killer cell cytotoxicity towards CD38+ multiple myeloma cell lines in a biochemical context mimicking tumour microenvironment conditions.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 6, p. 861, doi. 10.1007/s00262-018-2140-1
- By:
- Publication type:
- Article
The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells.
- Published in:
- Nature Medicine, 2015, v. 21, n. 6, p. 572, doi. 10.1038/nm.3867
- By:
- Publication type:
- Article
Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity.
- Published in:
- Nature Medicine, 2010, v. 16, n. 4, p. 483, doi. 10.1038/nm.2112
- By:
- Publication type:
- Article
Inhibition of Hsp90 attenuates inflammation in endotoxin-induced uveitis.
- Published in:
- FASEB Journal, 2007, v. 21, n. 9, p. 2113, doi. 10.1096/fj.06-7637com
- By:
- Publication type:
- Article
MGUS and Smoldering Myeloma: the Most Prevalent of Plasma Cell Dyscrasias.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 7, p. 594
- By:
- Publication type:
- Article
The role of tumour-stromal interactions in modifying drug response: challenges and opportunities.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 217, doi. 10.1038/nrd3870
- By:
- Publication type:
- Article
Lenalidomide for the treatment of relapsed and refractory multiple myeloma.
- Published in:
- Cancer Management & Research, 2012, v. 4, p. 253, doi. 10.2147/CMAR.S27087
- By:
- Publication type:
- Article
Bortezomib in the management of multiple myeloma.
- Published in:
- Cancer Management & Research, 2009, v. 1, p. 107
- By:
- Publication type:
- Article
An epigenomic approach to therapy for tamoxifen-resistant breast cancer.
- Published in:
- Cell Research, 2014, v. 24, n. 7, p. 809, doi. 10.1038/cr.2014.71
- By:
- Publication type:
- Article